At a glance
- Originator Takeda
- Developer Nonindustrial source; Takeda
- Class Antineoplastics
- Mechanism of Action 5-lipoxygenase inhibitors; Oxygen radical scavengers; Thromboxane synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Nephritis; Pancreatic cancer